newsfilter
← Latest News
GlobeNewswire·

Ovid Therapeutics to Present at Upcoming August Investor Conferences

NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by certain epilepsies and brain conditions,